Lung Cancer

  • Kenneth F. Kessel
  • Zdzislaw H. Piotrowski
  • William T. Leslie


Lung cancer is a major cause of death in the United States and the world. Paradoxically, it is one of the most preventable and least curable cancers. The 5-year survival rate for all patients with lung cancer in the United States in 1987 was 13%, an improvement over the 8% five-year survival rate in 1963.1 Mortality rates, however, have not changed significantly during the past two decades (Table 87.1). Important genetic and biologic research concerning early diagnostic biomarkers and new therapeutic approaches are under way. The key concept for the family physician is prevention. This chapter discusses an approach to the management of lung cancer through the three levels of prevention and the critical role the family physician plays in each.


Lung Cancer Small Cell Lung Cancer Family Physician Small Cell Carcinoma Asbestos Exposure 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Boring CC, Squires TS, Tong T. Cancer statistics, 1992. CA Cancer J Clin 1992;42:19–38.PubMedCrossRefGoogle Scholar
  2. 2.
    US Department of Health and Human Services. Healthy people 2000: national health promotion and disease prevention objectives: full report, with commentary. Washington, DC: Public Health Service, 1991. DHHS Publ. No. (PHS) 91–50212.Google Scholar
  3. 3.
    US Preventive Services Task Force. Guide to clinical preventive services: an assessment of the effectiveness of 169 interventions. Baltimore: William &amp Wilkins, 1989:289–95.Google Scholar
  4. 4.
    Fraumeni JF, Blot WJ. Lung and pleura. In: Shottenfeld D, Fraumeni JF, editors. Cancer epidemiology and prevention. Philadelphia: Saunders, 1982:564–82.Google Scholar
  5. 5.
    McDonald JC, McDonald AD. Epidemiology of asbestos-related lung cancer. In: Antman K, Aisner J, editors. Asbestos-related malignancy. Orlando, FL: Grune &amp Stratton, 1987:57–79.Google Scholar
  6. 6.
    Minna JD, Pass H, Glastein EL, Ihde DC. Cancer of the lung. In: De Vita VT, Hellman S, Rosenberg SA, editors. Cancer: principles and practice of oncology. Vol.1. 3rd ed. Philadelphia: J.B. Lippin-cott, 1989:591–705.Google Scholar
  7. 7.
    Elston RC, Chen VW, Bailey-Wilson JE, Rothschild H. Increased familial risk for lung cancer. J Natl Cancer Inst 1986;76:217–22.PubMedGoogle Scholar
  8. 8.
    Tocuhata GK, Lilienfeld AM. Familial aggregation of lung cancer in humans. J Natl Cancer Inst 1963;30:289–312.Google Scholar
  9. 9.
    Castonguay A. Methods and strategies in lung cancer control. Cancer Res 1992;52:2641s–51s.Google Scholar
  10. 10.
    Faber LP. Lung cancer. In: Holleb AI, Fink DJ, Murphy GP, editors. American Cancer Society textbook of clinical oncology. Atlanta: American Cancer Society, 1991:194–212.Google Scholar
  11. 11.
    Kritchevsky D. Diet and cancer. In: Holleb AI, Fink DJ, Murphy GP, editors. American Cancer Society textbook of clinical oncology. Atlanta: American Cancer Society, 1991:125–32.Google Scholar
  12. 12.
    Kramer BS. Biology and genetics of lung cancer: implications for early detection and prevention. In: Educational book, 27th annual meeting of American Society of Clinical Oncology; 1991 May 19–21. Houston: American Society of Clinical Oncology, 1991: 110–16.Google Scholar
  13. 13.
    Fontana RS. Screening for lung cancer: recent experience in the United States. Cancer Treat Res 1986;29:91–111.CrossRefGoogle Scholar
  14. 14.
    Mountain CF. A new international staging system for lung cancer. Chest 1986:89 Suppl 4:225s–33s.CrossRefGoogle Scholar
  15. 15.
    Vincent RG, Pickren JW, Lane WW, et al. Changing histopathol-ogy of lung cancer: a review. Cancer 1977;39:1647–55.PubMedCrossRefGoogle Scholar
  16. 16.
    Coy P, Kennelly GM. The role of curative radiotherapy in the treatment of lung cancer. Cancer 1980;45:698–702.PubMedCrossRefGoogle Scholar
  17. 17.
    Rapp E, Pater L, Willan A, et al. Chemotherapy can prolong survival in patients with advanced non-small-cell lung cancer—report of a Canadian multicenter randomized trial. J Clin Oncol 1988;6:633–41.PubMedGoogle Scholar
  18. 18.
    Academy of Hospice Physicians, 500 9th Street North, Suite 200, St. Petersburg, FL 33705.Google Scholar
  19. 19.
    McCormack A, Hunter-Smith D, Piotrowski ZH, Grant M, Kubik S, Kessel K. Analgesic use in home hospice cancer patients. J Fam Pract 1992;34:160–4.PubMedGoogle Scholar

Copyright information

© Springer Science+Business Media New York 1994

Authors and Affiliations

  • Kenneth F. Kessel
  • Zdzislaw H. Piotrowski
  • William T. Leslie

There are no affiliations available

Personalised recommendations